Complex regional pain syndrome, or CRPS, is a chronic pain condition that usually develops in an arm or leg after an injury, surgery, or other trauma. The pain is dramatically out of proportion to the original event: a simple wrist fracture or minor sprain can spiral into burning, swelling, skin color changes, and sensitivity so intense that a light breeze on the skin becomes unbearable. CRPS remains one of the more poorly understood and frequently misdiagnosed pain conditions in medicine, in part because no single blood test or imaging scan can confirm it and its underlying mechanisms cut across inflammation, the immune system, and the brain itself.
What CRPS Looks and Feels Like
The hallmark of CRPS is pain that far exceeds what the original injury would normally produce, and that persists long after the injury should have healed. But pain is only part of the picture. The affected limb often shows a cluster of changes that can shift over time:
- Sensory changes: Burning or throbbing pain, heightened sensitivity to touch or temperature (even clothing brushing against the skin can be agonizing), and sometimes a paradoxical numbness.
- Skin and color shifts: The skin on the affected limb may turn red, blue, purple, or blotchy white. Its texture can change too, becoming shiny, thin, or excessively sweaty.
- Temperature asymmetry: The affected limb often feels noticeably warmer or cooler than the other side. This difference can fluctuate from day to day.
- Swelling and stiffness: Edema in the affected area is common, and over time joints may stiffen, partly from disuse and partly from the disease process itself.
- Motor problems: Weakness, tremor, and decreased range of motion can develop, sometimes making it difficult to use the limb at all.
- Nail and hair changes: Abnormally fast or slow hair and nail growth on the affected limb is a frequent but often overlooked sign.
These features tend to cluster in a region rather than following a single nerve’s territory, which is one of the things that sets CRPS apart from a straightforward nerve injury. The constellation of signs and symptoms can wax and wane, making it especially confusing for patients and clinicians alike.
What Triggers It and Who Is at Risk
A fracture is one of the most common starting points. Wrist fractures in particular are considered a classic trigger for CRPS.1PubMed. Factors associated with complex regional pain syndrome type I in patients with surgically treated distal radius fracture But CRPS can follow almost any type of tissue insult: sprains, crush injuries, surgery, prolonged immobilization in a cast, and even minor events like needle sticks. In a smaller number of cases, no clear triggering event can be identified at all.
Women develop CRPS roughly three to four times more often than men, and the highest incidence occurs in women between about 60 and 70 years old.2PubMed. The incidence of complex regional pain syndrome: a population-based study A retrospective clinical study confirmed this sex imbalance, finding that about 73% of patients were women, with an average age around 61 for women and 52 for men.3PubMed Central. Comparison of Epidemiological Data of Complex Regional Pain Syndrome (CRPS) Patients in Relation to Disease Severity—A Retrospective Single-Center Study Why women, and especially postmenopausal women, face higher risk is not fully settled, though hormonal and immune factors are suspected.
Beyond sex and age, there is no reliable checklist of personality traits or psychological profiles that predict who will develop CRPS. The old notion that it is “all in your head” or the result of a particular psychological vulnerability has been largely discredited. Psychological distress is a consequence of living with severe chronic pain, not its root cause.
Type I vs. Type II
CRPS is divided into two types. Type I, which accounts for the vast majority of cases, develops without an identified injury to a specific nerve. Type II occurs when there is a confirmed, identifiable nerve lesion.4Cochrane Database of Systematic Reviews. Physiotherapy interventions for treating pain and disability in adults with complex regional pain syndrome types I and II You might expect two diseases that differ on something as fundamental as nerve damage to feel quite different, but that turns out not to be the case. When researchers carefully mapped the sensory profiles of type I and type II patients using standardized testing, the two groups had almost identical patterns, with the only notable difference being a stronger loss of light-touch detection in type II.5PubMed. Sensory signs in complex regional pain syndrome and peripheral nerve injury That finding has led many researchers to view the two types as points along a single disease continuum rather than fundamentally separate conditions.
There are some biological differences under the surface. Receptor activity on blood vessels and nerves in the skin tends to be higher in type II patients, and the patterns of receptor changes over time differ between the two types.6PubMed Central. Subtypes of complex regional pain syndrome—a systematic review of the literature But from the patient’s perspective, the experience of pain, swelling, and functional loss is largely the same, and the treatment approach does not hinge much on which type label has been assigned.
How CRPS Is Diagnosed
There is no definitive lab test or scan for CRPS. Diagnosis is clinical, meaning it relies on a doctor recognizing the right pattern of signs and symptoms and ruling out other explanations. The current standard is a set of criteria developed at a 2003 consensus conference in Budapest, known informally as the Budapest Criteria. They require that the patient report symptoms in at least three of four categories (sensory, blood-flow related, swelling/sweating, and motor/trophic) and that the clinician observe signs in at least two of those four categories during examination.
Validation studies showed that these criteria retain very high sensitivity (about 99%) while substantially improving specificity compared to the older system, which was catching far too many false positives.7PubMed Central. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome In practical terms, if you actually have CRPS, the Budapest Criteria will almost certainly flag it. And by requiring signs across multiple categories, they reduce the chance of mislabeling something else as CRPS.
The Budapest Criteria are not perfect in every population, though. In post-stroke patients who develop CRPS-like symptoms in a paralyzed limb, the criteria perform poorly, likely because the stroke itself causes overlapping neurological signs that confuse the picture.8PubMed. Validity of the Budapest Criteria For Poststroke Complex Regional Pain Syndrome That limitation matters because post-stroke CRPS is not rare, and clinicians working with stroke patients need to be aware that standard diagnostic checklists may miss or misclassify these cases.
What Is Going Wrong in the Body
CRPS is not a single malfunction. Research over the past two decades has revealed overlapping mechanisms across the peripheral nerves, the central nervous system, the autonomic nervous system, and the immune system. No single one of these fully explains the condition, and their relative importance likely varies from patient to patient.
Inflammation and Nerve Signaling Gone Haywire
Early after the triggering injury, there is a surge of neurogenic inflammation, meaning the nerves themselves release inflammatory chemicals into surrounding tissue. Increased production of cytokines and neuropeptides has been documented in CRPS patients, and this process amplifies the classic signs of redness, warmth, and swelling well beyond what the original injury would produce on its own.9PubMed. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS) In some patients, especially those with longer-lasting disease, small nerve fibers in the skin degenerate. This small-fiber damage may explain many features of CRPS, including spreading pain, skin hypersensitivity, abnormal sweating, and swelling, since small fibers control much of those functions.10PubMed. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? However, small-fiber loss appears in only a subset of type I patients, suggesting it develops as a consequence of ongoing disease activity rather than being the initial cause.11PubMed Central. Different Types of Pain in Complex Regional Pain Syndrome Require a Personalized Treatment Strategy
Changes in the Brain
The brain’s sensory maps physically reorganize in CRPS. Imaging studies have shown that the brain region representing the affected hand shrinks, and its boundaries shift toward areas representing the face. A systematic review and meta-analysis confirmed that the cortical representation of the affected hand is significantly smaller both compared to the unaffected hand and compared to healthy people without CRPS.12The Journal of Pain. Systematic Review and Meta-Analysis of Quantified Somatosensory Cortex Changes in Complex Regional Pain Syndrome Earlier work found that the degree of this remapping correlated strongly with the amount of pain the patient reported and with their sensitivity to touch on the affected side.13PubMed. Patterns of cortical reorganization in complex regional pain syndrome These brain changes help explain why CRPS patients sometimes feel that their limb no longer belongs to them or have distorted perception of its size and position in space.
Autonomic and Immune Dysfunction
The autonomic nervous system, which controls blood vessel tone, sweating, and skin temperature, is clearly disrupted in CRPS. Immune reactions, changes in the population of receptors on nerve fibers and blood vessels, and altered sympathetic nerve signaling from the brain all contribute to the temperature swings and color changes that characterize the affected limb.14PubMed. Complex regional pain syndrome: a focus on the autonomic nervous system
On top of that, there is growing evidence that CRPS has an autoimmune component. Researchers have found functional autoantibodies in the blood of CRPS patients that target specific receptors on cells, including the beta-2 adrenergic receptor and the muscarinic-2 receptor.15PubMed. Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome Follow-up experiments suggested that a majority of CRPS patients, but not healthy controls, carry autoantibodies that bind to and activate these receptors.16PubMed Central. Autoinflammatory and autoimmune contributions to complex regional pain syndrome If CRPS is indeed partly autoimmune, that opens the door to treatments that target the immune system directly, though this line of therapy is still largely experimental.
Treatment Approaches
There is no single cure for CRPS. Treatment usually involves layering multiple approaches, and what works for one patient may fail for another. Speed matters: the condition is widely considered more manageable when caught and treated early, before chronic changes in the nerves and brain become entrenched.17Springer Link / Current Pain and Headache Reports. Complex Regional Pain Syndrome (CRPS) and the Value of Early Detection
Medications
No drug is specifically approved for CRPS in most countries, so pharmacological treatment draws on medications developed for other pain conditions. The most encouraging drug evidence involves bisphosphonates, a class of medications more commonly associated with osteoporosis. A meta-analysis of randomized controlled trials found that bisphosphonates significantly reduced pain compared to placebo, both in the short term and at medium-term follow-up.18PubMed. Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo This makes sense given the bone-loss component of CRPS: many patients develop regional osteoporosis in the affected limb, and bisphosphonates address both the bone and the inflammatory pathways involved. Beyond bisphosphonates, clinicians commonly use neuropathic pain medications such as gabapentin and pregabalin, low-dose naltrexone, corticosteroids in early inflammatory phases, and sometimes ketamine infusions in refractory cases, though the evidence base for most of these is thinner.
Neuromodulation
When medications and rehabilitation alone are not enough, implantable devices that electrically stimulate parts of the nervous system can help. Spinal cord stimulation (SCS) has been used for CRPS for decades. In randomized trials, SCS produced a meaningful drop in pain intensity compared to controls, with about 39% of SCS patients reporting substantial improvement versus 6% of controls. However, SCS did not significantly improve physical function.19Interventional Pain Medicine. Spinal cord stimulation for the treatment of complex regional pain syndrome: A systematic review of randomized controlled trials
A newer approach targets the dorsal root ganglion, a nerve cluster near the spine. In a head-to-head randomized trial, dorsal root ganglion stimulation outperformed traditional spinal cord stimulation for lower-extremity CRPS: about 81% of patients receiving dorsal root ganglion stimulation achieved a meaningful pain reduction at three months, compared to roughly 56% in the spinal cord stimulation group.20PubMed Central. Dorsal Root Ganglion Stimulation for Lower Extremity Neuropathic Pain Syndromes: An Evidence-Based Literature Review An important practical advantage is durability: dorsal root ganglion stimulation provided stable pain relief through 12 months, while traditional spinal cord stimulation showed a decline in effectiveness at 9 and 12 months, particularly in CRPS type I patients.21PubMed. Therapy Habituation at 12 Months: Spinal Cord Stimulation Versus Dorsal Root Ganglion Stimulation for Complex Regional Pain Syndrome Type I and II
Physical Therapy and Motor Imagery
Physical rehabilitation is considered a cornerstone of CRPS management, but standard “push through the pain” exercise can backfire. Two specialized approaches have attracted research interest: graded motor imagery and mirror therapy. Graded motor imagery is a structured program that starts with mental recognition of left versus right limbs, progresses to imagined movements, and finishes with mirror therapy, where the patient watches the reflection of their healthy limb moving in place of the affected one. This sequence is thought to gradually retrain the brain’s distorted body maps.
A review of the evidence found that graded motor imagery and mirror therapy reduced pain by an average of about 20 points on a standardized neuropathic pain scale and produced functional improvements, with some reduction in swelling as well.22PubMed Central. Breaking the Cycle of Pain: The Role of Graded Motor Imagery and Mirror Therapy in Complex Regional Pain Syndrome That said, the evidence base remains thin. A systematic review concluded that while the techniques can improve pain in CRPS type I, there is not yet enough evidence to recommend them over other treatments, given the small and mixed study populations involved.23PubMed. Update on the effects of graded motor imagery and mirror therapy on complex regional pain syndrome type 1: A systematic review Practically, many clinicians still use them because the risk is low and the rationale (retraining a reorganized cortex) aligns well with what is known about the brain’s role in CRPS.
The Role of Fear and Psychology
Chronic CRPS frequently comes with anxiety, depression, and fear of movement, which is understandable when every attempt to use a limb triggers severe pain. Some rehabilitation programs, such as pain exposure physical therapy, directly confront movement avoidance by progressively loading the affected limb despite pain. An exploratory study of this approach found that fear-related beliefs about pain improved in patients undergoing both pain exposure therapy and conventional treatment. But here is the twist: the reduction in fear did not explain why pain exposure therapy worked any differently from conventional treatment.24PLOS ONE. Are Pain-Related Fears Mediators for Reducing Disability and Pain in Patients with Complex Regional Pain Syndrome Type 1? An Explorative Analysis on Pain Exposure Physical Therapy In other words, patients got less fearful in both groups, and that fear reduction alone did not account for the outcomes. The mechanism by which progressive loading helps CRPS patients remains genuinely unclear, which is an honest reflection of how much is still unknown about this condition.
CRPS in Children and Adolescents
CRPS is not just an adult condition, though it looks somewhat different in younger patients. Pediatric CRPS occurs predominantly in girls, with one review finding that about 90% of pediatric patients were female, at an average age of about 12.25Journal of Pediatric Orthopaedics. Pediatric Complex Regional Pain Syndrome Unlike adults, where the upper limb (particularly the hand and wrist) is the most common site, children overwhelmingly develop CRPS in the lower limbs, especially the foot. Minor trauma is the typical trigger in about 80% of pediatric cases.
Children with CRPS also tend to present differently on exam. The skin temperature of the affected limb at onset is more often cool rather than warm, and neurological and sympathetic signs tend to be less pronounced than in adults.26PubMed. Complex regional pain syndrome type I in children These differences can make the condition easy to miss, especially since many clinicians do not expect CRPS in a child. The encouraging news is that pediatric CRPS generally responds well to noninvasive treatments like physical therapy and psychological support, with most children eventually achieving full resolution of symptoms. Recurrences do happen, sometimes in a different limb, but the overall prognosis in children is substantially better than in adults.
The Life Impact of Living With CRPS
The toll of CRPS extends well beyond the affected limb. A multicenter survey of CRPS patients found that the unemployment rate among them was 57%, compared to just under 3% before their condition began. About 83% reported economic difficulties, and roughly 85% said they were unable to engage in economic activities at all.27Korean Journal of Pain. Multicenter survey of symptoms, work life, economic status, and quality of life of complex regional pain syndrome patients Those numbers capture something that clinical outcome measures often miss: CRPS can dismantle a person’s ability to work, socialize, and maintain financial stability. Quality of life scores in CRPS patients consistently rank among the lowest of any chronic pain condition, overlapping with those seen in end-stage cancer pain. This is not a condition that patients can simply “manage” with willpower.
Sensory Phenotyping and the Push Toward Personalized Treatment
One of the more promising research directions involves recognizing that “CRPS” may actually encompass several distinct subtypes defined not by the old type I/type II split, but by measurable differences in how the nervous system processes sensation. Researchers using standardized sensory testing have identified at least two distinct clusters among CRPS patients: one group with clear heightened pain sensitivity and significant loss of fine touch, and a second group whose sensory testing looks essentially normal despite meeting all the clinical criteria for CRPS.28PAIN Reports. Sensory phenotypes in complex regional pain syndrome and chronic low back pain—indication of common underlying pathomechanisms A large multicentre study involving over 600 CRPS patients has been building on this work, using detailed sensory profiling to classify patients into data-driven subtypes.29PubMed. Sensory data-driven classification of complex regional pain syndrome: a multicentre cohort study
Why does this matter? Because if two patients both carry a CRPS diagnosis but have fundamentally different nervous-system profiles, they may need different treatments. The patient with obvious sensory hypersensitivity might benefit most from medications that calm overactive nerve signaling, while the patient with a normal sensory profile might respond better to approaches targeting inflammation or autoimmune processes. Phenotyping is still a research tool rather than a routine clinical practice, but it represents the field’s clearest path toward matching patients with treatments that are actually likely to help them.
The Name Problem
If you have been reading about CRPS online, you have probably encountered a confusing tangle of older names. The condition has been called reflex sympathetic dystrophy, causalgia, Sudeck’s atrophy, algodystrophy, and shoulder-hand syndrome, among others. The shifting terminology tracks the history of medical understanding. Silas Weir Mitchell described causalgia in soldiers wounded during the American Civil War. Paul Sudeck later used early X-rays to document the bone loss that followed limb trauma. René Leriche championed the idea that the sympathetic nervous system was the key driver, which gave rise to the “reflex sympathetic dystrophy” label that persisted for decades.30PubMed Central. Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues The umbrella term “complex regional pain syndrome” was adopted in 1994 precisely because none of the older names accurately captured what was happening. “Reflex sympathetic dystrophy” implied the sympathetic nervous system was always the central culprit, which turned out to be only part of the story in some patients and irrelevant in others. If your doctor or an older medical record uses one of these legacy terms, they are almost certainly talking about the same condition now called CRPS.